This is what economists might  call a problem of the commons, and the problem of the commons is exactly what we face in the case  of antibiotics as well: that we don't consider — and we, including individuals, patients, hospitals, entire health systems — do not consider the costs  that they impose on others by the way antibiotics are actually used.
Na economía chamaríanlle a isto a traxedia dos bens comúns e é o mesmo problema  que temos cos antibióticos, que nós non temos en conta —nós inclúe a todo individuo, pacientes, hospitais, sistemas de saúde completos— non temos en conta os custos  que lles impoñemos aos demais debido a como empregamos os antibióticos.